AMN Healthcare Services (AMN) 10-Q 1 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Oct. 30, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'AMN HEALTHCARE SERVICES INC	'
Entity Central Index Key	'0001142750	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-13	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	46,008,760

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$31,653	$5,681
Accounts receivable, net of allowances of $4,512 and $5,003 at September 30, 2013 and December 31, 2012, respectively	144,933	142,510
Accounts receivable, subcontractor	18,869	18,467
Deferred income taxes, net	17,642	18,123
Prepaid and other current assets	13,183	18,963
Total current assets	226,280	203,744
Restricted cash, cash equivalents and investments	22,039	18,861
Fixed assets, net	17,405	14,815
Other assets	23,002	19,732
Goodwill	123,324	123,324
Intangible assets, net	132,127	136,910
Total assets	544,177	517,386
Current liabilities:	'	'
Accounts payable and accrued expenses	54,842	52,619
Accrued compensation and benefits	54,220	49,443
Other current liabilities	6,251	7,463
Total current liabilities	115,313	109,525
Notes payable, net of discount	148,616	158,178
Other long-term liabilities	71,976	67,572
Total liabilities	335,905	335,275
Commitments and contingencies (Note 9)	'	'
Stockholders’ equity:	'	'
Preferred stock, $0.01 par value; 10,000 shares authorized (including 5,941 shares of series A conditional convertible preferred stock); none issued and outstanding at September 30, 2013 and December 31, 2012	0	0
Common stock, $0.01 par value; 200,000 shares authorized; 46,009 and 45,691 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively	460	457
Additional paid-in capital	427,905	424,292
Accumulated deficit	-219,631	-242,195
Accumulated other comprehensive loss	-462	-443
Total stockholders’ equity	208,272	182,111
Total liabilities and stockholders’ equity	$544,177	$517,386

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, except Per Share data, unless otherwise specified
Accounts receivable, allowance	$4,512	$5,003
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series A conditional convertible preferred stock, shares authorized	5,941	5,941
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	46,009	45,691
Common stock, shares outstanding	46,009	45,691

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue	$257,095	$243,912	$763,158	$706,110
Cost of revenue	181,428	174,329	540,071	506,340
Gross profit	75,667	69,583	223,087	199,770
Operating expenses:	'	'	'	'
Selling, general and administrative	55,605	52,375	163,763	149,855
Depreciation and amortization	3,317	3,435	9,847	10,682
Total operating expenses	58,922	55,810	173,610	160,537
Income from operations	16,745	13,773	49,477	39,233
Interest expense, net	1,840	3,688	7,829	22,811
Income from continuing operations before income taxes	14,905	10,085	41,648	16,422
Income tax expense	6,290	4,227	17,071	7,192
Income from continuing operations	8,615	5,858	24,577	9,230
Income from discontinued operations, net of tax	0	0	0	823
Net income	8,615	5,858	24,577	10,053
Basic income per common share from:	'	'	'	'
Continuing operations (in dollars per share)	$0.19	$0.13	$0.53	$0.20
Discontinued operations (in dollars per share)	$0	$0	$0	$0.02
Net income (in dollars per share)	$0.19	$0.13	$0.53	$0.22
Diluted income per common share from:	'	'	'	'
Continuing operations (in dollars per share)	$0.18	$0.12	$0.51	$0.20
Discontinued operations (in dollars per share)	$0	$0	$0	$0.02
Net income (in dollars per share)	$0.18	$0.12	$0.51	$0.22
Weighted average common shares outstanding:	'	'	'	'
Basic (shares)	45,986	40,850	45,947	40,747
Diluted (shares)	47,810	46,897	47,776	46,512
Other comprehensive loss - foreign currency translation	-84	-55	-19	-65
Comprehensive income	$8,531	$5,803	$24,558	$9,988

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement of Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
In Thousands, unless otherwise specified
Balance at Dec. 31, 2012	$182,111	$457	$424,292	$0	($242,195)	($443)
Balance, Shares at Dec. 31, 2012	'	45,691	'	'	'	'
Statement of Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Settlement of acquisition share holdback, value	-3,046	'	'	-3,046	'	'
Treasury stock retirement, share	'	-204	'	'	'	'
Treasury stock retirement, value	0	-2	-1,031	3,046	-2,013	'
Equity awards vested and issued and exercised, share	'	522	'	'	'	'
Equity awards vested and issued and exercised, value	-1,488	5	-1,493	'	'	'
Income tax benefit from equity awards vested and issued and exercised	1,470	'	1,470	'	'	'
Share-based compensation	4,667	'	4,667	'	'	'
Comprehensive income (loss)	24,558	'	'	'	24,577	-19
Balance at Sep. 30, 2013	$208,272	$460	$427,905	$0	($219,631)	($462)
Balance, Shares at Sep. 30, 2013	'	46,009	'	'	'	'

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:	'	'
Net income	$24,577	$10,053
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	9,847	10,682
Non-cash interest expense	1,050	2,346
Loss on debt extinguishment	434	9,815
Increase in allowances for doubtful accounts and sales credits	2,679	5,302
Provision for deferred income taxes	1,951	4,447
Share-based compensation	4,667	4,578
Excess tax benefits from share-based compensation	-1,529	-12
Holdback settlement in equity from prior acquisition	-3,046	0
Gain on sale of discontinued operations	0	-1,187
Loss on disposal or sale of fixed assets	13	16
Changes in assets and liabilities, net of effects from divestiture:	'	'
Accounts receivable, net	-5,102	-529
Accounts receivable, subcontractor	-402	2,811
Prepaid expenses and other current assets	5,181	-2,856
Other assets	-3,731	-2,104
Accounts payable and accrued expenses	1,572	-6,222
Accrued compensation and benefits	4,777	5,597
Other liabilities	3,386	-675
Restricted cash, cash equivalents and investments balance	-3,225	0
Net cash provided by operating activities	43,099	42,062
Cash flows from investing activities:	'	'
Purchase and development of fixed assets	-6,447	-3,753
Proceeds from sales of assets held for sale	600	8,644
Change in restricted cash, cash equivalents and investments balance	47	-673
Net cash (used in) provided by investing activities	-5,800	4,218
Cash flows from financing activities:	'	'
Capital lease repayments	-479	-492
Proceeds from revolving credit facility	1,000	0
Payments on revolving credit facility	-1,000	-3,000
Repayments of prior notes payable	0	-206,500
Payments on term loan credit facility	-10,000	-28,380
Proceeds from term loan credit facility, net of discount	0	198,000
Payment of financing costs	-935	-3,938
Prepayment penalty associated with the prior credit facilities	0	-1,200
Proceeds from exercise of equity awards	1,174	0
Cash paid for shares withheld for taxes	-2,662	-872
Excess tax benefits from share-based compensation	1,529	12
Change in bank overdraft	65	16
Net cash used in financing activities	-11,308	-46,354
Effect of exchange rate changes on cash	-19	-65
Net increase in cash and cash equivalents	25,972	-139
Cash and cash equivalents at beginning of period	5,681	3,962
Cash and cash equivalents at end of period	31,653	3,823
Supplemental disclosures of cash flow information:	'	'
Cash paid for interest (net of $63 and $27 capitalized for the nine months ended September 30, 2013 and 2012, respectively)	4,253	10,992
Cash paid for income taxes	$14,708	$363

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (Parenthetical) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Interest capitalized	$63	$27

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Presentation	'
	BASIS OF PRESENTATION
	The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income, stockholders’ equity and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted only of normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.
	The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, 2012, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012, filed with the Securities and Exchange Commission (“SEC”) on February 22, 2013.
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, valuation and recognition of share-based payments and income taxes. Actual results could differ from those estimates under different assumptions or conditions.
	Certain amounts in the unaudited condensed consolidated financial statements for the nine months ended September 30, 2012 have been reclassified to conform to the nine months ended September 30, 2013 presentation.
	Recently Adopted Accounting Pronouncements
	In July 2012, the Financial Accounting Standards Board issued an accounting standard update intended to simplify how an entity tests indefinite-lived intangible assets other than goodwill for impairment by providing entities with an option to perform a qualitative assessment to determine whether further impairment testing is necessary. This accounting standard update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted this guidance effective January 1, 2013 and such adoption did not have a material effect on its unaudited condensed consolidated financial statements.

Discontinued_Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2013
Discontinued Operations and Disposal Groups [Abstract]	'
DISCONTINUED OPERATIONS	'
	DISCONTINUED OPERATIONS
	In January 2012, the Company completed the sale of its home healthcare services segment and the related results of operations have been classified as discontinued operations for the nine months ended September 30, 2012. The following table represents the revenue and the components of discontinued operations, net of tax:
		Nine months ended September 30, 2012
	Revenue	$	3,885
	Loss before income taxes	(547		)
	Income tax benefit	183
	Loss from discontinued operations	(364		)
	Gain on sale of discontinued operations, before income taxes	3,825
	Income tax expense	(2,638		)
	Gain on sale of discontinued operations	1,187
	Total income from discontinued operations	$	823

Revenue_Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2013
Revenue Recognition [Abstract]	'
REVENUE RECOGNITION	'
	REVENUE RECOGNITION
	Revenue consists of fees earned from the permanent and temporary placement of clinicians and physicians. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its clinicians and physicians along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client. Payables to subcontractors of $19,413 and $18,129, respectively, were included in accounts payable and accrued expenses in the unaudited condensed consolidated balance sheet as of September 30, 2013 and the audited condensed consolidated balance sheet as of December 31, 2012.

Net_Income_Per_Common_Share

Net Income Per Common Share	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]	'
NET INCOME PER COMMON SHARE	'
	NET INCOME PER COMMON SHARE
	Securities that are entitled to participate in dividends with common stock, such as the Company’s Series A Conditional Convertible Preferred Stock (the “Preferred Stock”) that were outstanding during the three and nine months ended September 30, 2012, were considered to be participating securities and the two-class method was used for purposes of calculating basic net income per share. Under the two-class method, a portion of net income was allocated to these participating securities and excluded from the calculation of basic net income per common share. On December 21, 2012, all outstanding shares of Preferred Stock were converted into shares of common stock. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments and common stock issuable upon conversion of the Preferred Stock.
	Share-based awards to purchase 296 and 313 shares of common stock for the three and nine months ended September 30, 2013, respectively, were not included in the calculation of diluted net income per common share because the effect of these instruments was anti-dilutive. Share-based awards to purchase 1,964 and 2,164 shares of common stock for the three and nine months ended September 30, 2012, were not included in the calculation of diluted net income per common share because the effect of these instruments was anti-dilutive.
	The following table sets forth the computation of basic and diluted net income per common share for the three and nine months ended September 30, 2013 and 2012, respectively:
		Three Months Ended September 30,					Nine Months Ended September 30,
		2013		2012			2013		2012
	Income from continuing operations	$	8,615	$	5,858		$	24,577	$	9,230
	Income from discontinued operations, net of tax	—		—			—		823
	Net income	$	8,615	$	5,858		$	24,577	$	10,053
	Less: Allocation to participating securities - from continuing operations	—		(575		)	—		(905		)
	Allocation to participating securities - from discontinued operations	—		—			—		(81		)
	Total allocation to participating securities	—		(575		)	—		(986		)
	Net income attributable to common stockholders - basic	$	8,615	$	5,283		$	24,577	$	9,067
	Basic income per common share from:
	Continuing operations	$	0.19	$	0.13		$	0.53	$	0.2
	Discontinued operations	0		0			0		0.02
	Net income	$	0.19	$	0.13		$	0.53	$	0.22
	Diluted income per common share from:
	Continuing operations	$	0.18	$	0.12		$	0.51	$	0.2
	Discontinued operations	0		0			0		0.02
	Net income	$	0.18	$	0.12		$	0.51	$	0.22
	Weighted average common shares outstanding—basic	45,986		40,850			45,947		40,747
	Plus dilutive effect of potential common shares	1,824		6,047			1,829		5,765
	Weighted average common shares outstanding—diluted	47,810		46,897			47,776		46,512

Segment_Information

Segment Information	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]	'
SEGMENT INFORMATION	'
	SEGMENT INFORMATION
	The Company has three reportable segments: nurse and allied healthcare staffing, locum tenens staffing and physician permanent placement services.
	The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income includes income from continuing operations before depreciation, amortization of intangible assets, share-based compensation expense, interest expense (net) and other unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.
	The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:
		Three Months Ended September 30,				Nine Months Ended September 30,
		2013		2012		2013		2012
	Revenue
	Nurse and allied healthcare staffing	$	170,955	$	166,331	$	517,858	$	478,832
	Locum tenens staffing	75,253		67,591		213,417		198,692
	Physician permanent placement services	10,887		9,990		31,883		28,586
		$	257,095	$	243,912	$	763,158	$	706,110
	Segment Operating Income
	Nurse and allied healthcare staffing	$	20,392	$	18,785	$	62,994	$	54,306
	Locum tenens staffing	7,547		6,298		17,347		16,805
	Physician permanent placement services	2,205		2,201		6,735		5,797
		30,144		27,284		87,076		76,908
	Unallocated corporate overhead	8,595		8,507		23,085		22,418
	Depreciation and amortization	3,317		3,435		9,847		10,682
	Share-based compensation	1,487		1,569		4,667		4,575
	Interest expense, net	1,840		3,688		7,829		22,811
	Income from continuing operations before income taxes	$	14,905	$	10,085	$	41,648	$	16,422

Fair_Value_Measurement

Fair Value Measurement	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
FAIR VALUE MEASUREMENT	'
	FAIR VALUE MEASUREMENT
	The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
	Level 1—Quoted prices in active markets for identical assets or liabilities.
	Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	Financial assets and liabilities
	The Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. As of September 30, 2013 and December 31, 2012, the Company held certain assets that are required to be measured at fair value on a recurring basis. These included the restricted cash equivalents and investments and the Company’s investments associated with its deferred compensation plan. The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds, and the fair values are based on quoted prices in active markets for identical assets. The Company’s investments associated with its deferred compensation plan typically consist of money market funds and mutual funds that are publicly traded and for which market prices are readily available.
	Financial assets measured at fair value on a recurring basis are summarized below:
		Fair Value Measurements as of September 30, 2013
		Total		Quoted Prices in		Significant		Significant
				Active Markets		Other		Unobservable
				for Identical		Observable		Inputs
				Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	U.S. Treasury securities	$	17,819	$	17,819	$	—	$	—
	Trading securities investment	357		357		—		—
	Total financial assets measured at fair value	$	18,176	$	18,176	$	—	$	—
		Fair Value Measurements as of December 31, 2012
		Total		Quoted Prices in		Significant		Significant
				Active Markets		Other		Unobservable
				for Identical		Observable		Inputs
				Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	U.S. Treasury securities	$	18,298	$	18,298	$	—	$	—
	Trading securities investment	42		42		—		—
	Total financial assets measured at fair value	$	18,340	$	18,340	$	—	$	—
	Non-financial assets and liabilities
	The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill and indefinite-lived intangible assets accounted for pursuant to accounting guidance on goodwill and other intangible assets.
	The Company evaluates goodwill at the reporting unit level and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determined the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.
	The Company performed the annual impairment testing at October 31, 2012, and determined there was no impairment of goodwill. No events have occurred subsequent to October 31, 2012 that indicate impairment may have occurred. The Company did not have any significant non-financial assets or liabilities measured at fair value on December 31, 2012 and September 30, 2013.

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	INCOME TAXES
	The Company currently estimates its annual effective income tax rate will be approximately 40.5% for 2013, as compared to the 40.3% effective income tax rate from continuing operations in 2012. The difference in effective tax rates for 2012 and the forecasted rate for 2013 is primarily due to the relationship of pre-tax income to permanent differences.
	In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. Significant differences between pre-tax income and taxable income for recent years are related to goodwill impairment and other permanent differences. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will realize the benefits of these deductible differences. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced.
	The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of September 30, 2013, the Company is no longer subject to U.S. federal, state, local or foreign examinations by tax authorities for years before 2005.
	The Internal Revenue Service ("IRS") has issued a Revenue Agent Report (RAR) to the Company related to its recently completed tax examination. The RAR seeks adjustments to the Company's taxable income for 2007-2010 and net operating loss carryforwards from 2005-2006. The adjustments to the Company's taxable income relate to the proposed disallowance of certain per diems paid to our clinicians and locum tenens providers on the Company's income tax return. Concurrent with the RAR, the Company received an Employment Tax Examination Report (ETER) for 2009 and 2010. The ETER adjustments propose additional Company payroll tax liabilities and penalties related to the treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER are mutually exclusive. The RAR and ETER contain multiple tax positions, some of which are contrary to each other. Thus, the Company is unable to determine any reasonable range of potential claim at this time.
	The Company has filed a Protest Letter for both the RAR and ETER and intends to defend its position. The Company does not expect resolution of this matter within twelve months and cannot predict with certainty the timing of such resolution. The Company believes its reserve for unrecognized tax benefits and contingent tax issues is adequate. Notwithstanding, the Company could adjust its provision for income taxes and or contingent tax liability based on future developments.

Notes_Payable_and_Related_Cred

Notes Payable and Related Credit Agreement	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
NOTES PAYABLE AND RELATED CREDIT AGREEMENT	'
	NOTES PAYABLE AND RELATED CREDIT AGREEMENT
	In April 2012, the Company entered into a Credit Agreement that provides two credit facilities (the “Credit Facilities”), including (A) a $50,000 revolving credit facility (the “Revolver”) and (B) a $200,000 face value secured term loan credit facility, net of unamortized original issue discount of $2,000 (the “Term Loan”). The Company entered into the First Amendment to the Credit Agreement (the “First Amendment”) with the lenders under the Credit Facilities, which went into effect on April 9, 2013.
	Among other things, the First Amendment amended the Credit Agreement as follows:
	•	Reduction in the Interest Rate on the Revolver. Under the original Credit Agreement, borrowings under the Revolver bore interest at floating rates based upon either a LIBOR or a base rate option selected by the Company, plus a spread (the “LIBOR Loan Spread”) of 3.75% to 4.25% and a spread (the “Base Rate Loan Spread”) of 2.75% to 3.25%, respectively, in each case, as specifically determined quarterly based upon the Company’s then-existing consolidated leverage ratio (as defined in the Credit Agreement). The First Amendment reduces each of the Revolver LIBOR Loan Spread and the Revolver Base Rate Loan Spread by 150 basis points, to 2.25% to 2.75% and 1.25% to 1.75%, respectively.
	•	Reduction in the Interest Rate on the Term Loan. Under the original Credit Agreement, borrowings under the Term Loan bore interest at floating rates based upon either a LIBOR (with a floor of 1.25%) or a base rate option selected by the Company, plus a LIBOR Loan Spread of 4.50% to 4.75% and a Base Rate Loan Spread of 3.50% to 3.75%, respectively, in each case, as specifically determined quarterly based upon the Company’s then-existing consolidated leverage ratio. The First Amendment reduces each of the Term Loan LIBOR Loan Spread and the Term Loan Base Rate Loan Spread by 150 to 175 basis points (depending on the original Credit Agreement Consolidated Leverage Ratio step) to 3.00% and 2.00%, respectively. It also reduces the LIBOR floor by 50 basis points, from 1.25% to 0.75%.
	•	Increased Sublimit for the Issuance of Letter of Credit. The original Credit Agreement provided for a $20,000 sublimit for the issuance of letters of credit under the Revolver. The First Amendment increases the sublimit to $30,000.
	In connection with the First Amendment, the Company incurred $935 in deferred financing fees, of which $364 were capitalized and are amortized to interest expense over the remaining term of the Credit Agreement and the remaining amount was recorded as interest expense in April 2013. In addition, in April 2013, the Company wrote off to interest expense $434 of unamortized deferred financing fees and original issue discount resulting from the First Amendment.

Commitments_and_Contingencies_

Commitments and Contingencies: Legal	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES: LEGAL	'
	COMMITMENTS AND CONTINGENCIES: LEGAL
	The Company is subject to various claims and legal actions in the ordinary course of its business. Some of these matters relate to professional liability, tax, payroll, contract and employee-related matters and include individual and collective lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment practices. The most significant matter of which the Company is currently the defendant is a class action related to wage and hour claims. In the second quarter of 2013, the Company reached a settlement with the plaintiffs in such action (and a related action) for an immaterial amount, which settlement is subject to the final approval of the Court. At September 30, 2013, the Company had fully reserved for the settlement of such action, which had been accrued in prior periods and was included in accounts payable and accrued expenses in the unaudited condensed consolidated balance sheet at September 30, 2013.
	Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by the Company’s clinicians and physicians. From time to time, and depending upon the particular facts and circumstances, the Company may be subject to indemnification obligations under its contracts with such clients relating to these matters.

Treasury_Stock

Treasury Stock	9 Months Ended
	Sep. 30, 2013
Treasury Stock Transactions, Excluding Value of Shares Reissued [Abstract]	'
TREASURY STOCK	'
	TREASURY STOCK
	In connection with the 2010 acquisition of NF Investors, Inc., a Delaware corporation ("NFI"), the parent company of Medfinders, 457 shares of the Company's common stock remained in escrow as of December 31, 2012 for potential Company indemnification claims. During the second quarter of 2013, the Company and former NFI selling shareholders agreed to release all 457 shares in escrow as follows: 1) 204 shares were returned to the Company for settlement of certain indemnification claims, which have been recorded as a $3,046 benefit offsetting selling, general and administrative expenses for the three and six months ended June 30, 2013 and classified as treasury stock on the unaudited condensed consolidated balance sheet at June 30, 2013; and 2) the remaining 253 shares were released from escrow to the former NFI selling shareholders. During the third quarter of 2013, the Company cancelled and retired all 204 shares of treasury stock. Upon cancellation and retirement, these shares were returned to the status of authorized and unissued.

Basis_of_Presentation_Policies

Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Use of Estimates	'
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, valuation and recognition of share-based payments and income taxes. Actual results could differ from those estimates under different assumptions or conditions.
Reclassification	'
	Certain amounts in the unaudited condensed consolidated financial statements for the nine months ended September 30, 2012 have been reclassified to conform to the nine months ended September 30, 2013 presentation.
Recently Adopted Accounting Pronouncements	'
	In July 2012, the Financial Accounting Standards Board issued an accounting standard update intended to simplify how an entity tests indefinite-lived intangible assets other than goodwill for impairment by providing entities with an option to perform a qualitative assessment to determine whether further impairment testing is necessary. This accounting standard update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted this guidance effective January 1, 2013 and such adoption did not have a material effect on its unaudited condensed consolidated financial statements.
Revenue Recognition	'
	Revenue consists of fees earned from the permanent and temporary placement of clinicians and physicians. Revenue is recognized when earned and realizable. The Company has entered into certain contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its clinicians and physicians along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its vendor management services. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client.
Net Income per Common Share	'
	Securities that are entitled to participate in dividends with common stock, such as the Company’s Series A Conditional Convertible Preferred Stock (the “Preferred Stock”) that were outstanding during the three and nine months ended September 30, 2012, were considered to be participating securities and the two-class method was used for purposes of calculating basic net income per share. Under the two-class method, a portion of net income was allocated to these participating securities and excluded from the calculation of basic net income per common share. On December 21, 2012, all outstanding shares of Preferred Stock were converted into shares of common stock. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments and common stock issuable upon conversion of the Preferred Stock.
Segment Information	'
	The Company’s management relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income includes income from continuing operations before depreciation, amortization of intangible assets, share-based compensation expense, interest expense (net) and other unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.
Fair Value Measurement	'
	The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
	Level 1—Quoted prices in active markets for identical assets or liabilities.
	Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	Financial assets and liabilities
	The Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
	Non-financial assets and liabilities
	The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill and indefinite-lived intangible assets accounted for pursuant to accounting guidance on goodwill and other intangible assets.
	The Company evaluates goodwill at the reporting unit level and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determined the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.
Income Taxes	'
	In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. Significant differences between pre-tax income and taxable income for recent years are related to goodwill impairment and other permanent differences. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will realize the benefits of these deductible differences. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced.

Discontinued_Operations_Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2013
Discontinued Operations and Disposal Groups [Abstract]	'
Components of discontinued operations, net of tax	'
	The following table represents the revenue and the components of discontinued operations, net of tax:
		Nine months ended September 30, 2012
	Revenue	$	3,885
	Loss before income taxes	(547		)
	Income tax benefit	183
	Loss from discontinued operations	(364		)
	Gain on sale of discontinued operations, before income taxes	3,825
	Income tax expense	(2,638		)
	Gain on sale of discontinued operations	1,187
	Total income from discontinued operations	$	823

Net_Income_Per_Common_Share_Ta

Net Income Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Computation of basic and diluted net income per common share	'
	The following table sets forth the computation of basic and diluted net income per common share for the three and nine months ended September 30, 2013 and 2012, respectively:
		Three Months Ended September 30,					Nine Months Ended September 30,
		2013		2012			2013		2012
	Income from continuing operations	$	8,615	$	5,858		$	24,577	$	9,230
	Income from discontinued operations, net of tax	—		—			—		823
	Net income	$	8,615	$	5,858		$	24,577	$	10,053
	Less: Allocation to participating securities - from continuing operations	—		(575		)	—		(905		)
	Allocation to participating securities - from discontinued operations	—		—			—		(81		)
	Total allocation to participating securities	—		(575		)	—		(986		)
	Net income attributable to common stockholders - basic	$	8,615	$	5,283		$	24,577	$	9,067
	Basic income per common share from:
	Continuing operations	$	0.19	$	0.13		$	0.53	$	0.2
	Discontinued operations	0		0			0		0.02
	Net income	$	0.19	$	0.13		$	0.53	$	0.22
	Diluted income per common share from:
	Continuing operations	$	0.18	$	0.12		$	0.51	$	0.2
	Discontinued operations	0		0			0		0.02
	Net income	$	0.18	$	0.12		$	0.51	$	0.22
	Weighted average common shares outstanding—basic	45,986		40,850			45,947		40,747
	Plus dilutive effect of potential common shares	1,824		6,047			1,829		5,765
	Weighted average common shares outstanding—diluted	47,810		46,897			47,776		46,512

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'
	The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment’s internal financial information as used for corporate management purposes:
		Three Months Ended September 30,				Nine Months Ended September 30,
		2013		2012		2013		2012
	Revenue
	Nurse and allied healthcare staffing	$	170,955	$	166,331	$	517,858	$	478,832
	Locum tenens staffing	75,253		67,591		213,417		198,692
	Physician permanent placement services	10,887		9,990		31,883		28,586
		$	257,095	$	243,912	$	763,158	$	706,110
	Segment Operating Income
	Nurse and allied healthcare staffing	$	20,392	$	18,785	$	62,994	$	54,306
	Locum tenens staffing	7,547		6,298		17,347		16,805
	Physician permanent placement services	2,205		2,201		6,735		5,797
		30,144		27,284		87,076		76,908
	Unallocated corporate overhead	8,595		8,507		23,085		22,418
	Depreciation and amortization	3,317		3,435		9,847		10,682
	Share-based compensation	1,487		1,569		4,667		4,575
	Interest expense, net	1,840		3,688		7,829		22,811
	Income from continuing operations before income taxes	$	14,905	$	10,085	$	41,648	$	16,422

Fair_Value_Measurement_Tables

Fair Value Measurement (Tables)	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'
	Financial assets measured at fair value on a recurring basis are summarized below:
		Fair Value Measurements as of September 30, 2013
		Total		Quoted Prices in		Significant		Significant
				Active Markets		Other		Unobservable
				for Identical		Observable		Inputs
				Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	U.S. Treasury securities	$	17,819	$	17,819	$	—	$	—
	Trading securities investment	357		357		—		—
	Total financial assets measured at fair value	$	18,176	$	18,176	$	—	$	—
		Fair Value Measurements as of December 31, 2012
		Total		Quoted Prices in		Significant		Significant
				Active Markets		Other		Unobservable
				for Identical		Observable		Inputs
				Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	U.S. Treasury securities	$	18,298	$	18,298	$	—	$	—
	Trading securities investment	42		42		—		—
	Total financial assets measured at fair value	$	18,340	$	18,340	$	—	$	—

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Components of discontinued operations, net of tax	'	'	'	'
Gain on sale of discontinued operations	'	'	$0	$1,187
Total income from discontinued operations	0	0	0	823
Healthcare services segment [Member]	'	'	'	'
Components of discontinued operations, net of tax	'	'	'	'
Revenue	'	'	'	3,885
Loss before income taxes	'	'	'	-547
Income tax benefit	'	'	'	183
Loss from discontinued operations	'	'	'	-364
Gain on sale of discontinued operations, before income taxes	'	'	'	3,825
Income tax expense	'	'	'	-2,638
Gain on sale of discontinued operations	'	'	'	1,187
Total income from discontinued operations	'	'	'	$823

Revenue_Recognition_Details

Revenue Recognition (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Revenue Recognition [Abstract]	'	'
Accounts Payable to Subcontractor	$19,413	$18,129

Net_Income_Per_Common_Share_De

Net Income Per Common Share (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Earnings Per Share [Abstract]	'	'	'	'
Common stock excluded from calculation of EPS	296	1,964	313	2,164
Computation of basic and diluted net income per common share	'	'	'	'
Income from continuing operations	$8,615	$5,858	$24,577	$9,230
Income from discontinued operations, net of tax	0	0	0	823
Net income	8,615	5,858	24,577	10,053
Less: Allocation to participating securities - from continuing operations	0	-575	0	-905
Allocation to participating securities - from discontinued operations	0	0	0	-81
Total allocation to participating securities	0	-575	0	-986
Net income attributable to common stockholders - basic	$8,615	$5,283	$24,577	$9,067
Basic income per common share from:	'	'	'	'
Continuing operations (in dollars per share)	$0.19	$0.13	$0.53	$0.20
Discontinued operations (in dollars per share)	$0	$0	$0	$0.02
Net income (in dollars per share)	$0.19	$0.13	$0.53	$0.22
Diluted income per common share from:	'	'	'	'
Continuing operations (in dollars per share)	$0.18	$0.12	$0.51	$0.20
Discontinued operations (in dollars per share)	$0	$0	$0	$0.02
Net income (in dollars per share)	$0.18	$0.12	$0.51	$0.22
Weighted average common shares outstanding—basic	45,986	40,850	45,947	40,747
Plus dilutive effect of potential common shares	1,824	6,047	1,829	5,765
Weighted average common shares outstanding—diluted	47,810	46,897	47,776	46,512

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
			segment
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	$257,095	$243,912	$763,158	$706,110
Operating Income	16,745	13,773	49,477	39,233
Depreciation and amortization	3,317	3,435	9,847	10,682
Share-based compensation	1,487	1,569	4,667	4,575
Interest expense, net	1,840	3,688	7,829	22,811
Income from continuing operations before income taxes	14,905	10,085	41,648	16,422
Segment Information (Textual) [Abstract]	'	'	'	'
Reportable business segments	'	'	3	'
Operating segments [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	257,095	243,912	763,158	706,110
Operating Income	30,144	27,284	87,076	76,908
Operating segments [Member] | Nurse and allied healthcare staffing [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	170,955	166,331	517,858	478,832
Operating Income	20,392	18,785	62,994	54,306
Operating segments [Member] | Locum tenens staffing [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	75,253	67,591	213,417	198,692
Operating Income	7,547	6,298	17,347	16,805
Operating segments [Member] | Physician permanent placement services [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Revenue	10,887	9,990	31,883	28,586
Operating Income	2,205	2,201	6,735	5,797
Corporate, non-segment [Member]	'	'	'	'
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'	'	'	'
Unallocated corporate overhead	$8,595	$8,507	$23,085	$22,418

Fair_Value_Measurement_Financi

Fair Value Measurement - Financial Assets and Liabilities (Details) (USD $)	0 Months Ended
	Oct. 31, 2012	Sep. 30, 2013	Dec. 31, 2012
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	$18,176,000	$18,340,000
Impairment charges	0	'	'
US Treasury securities [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	17,819,000	18,298,000
Trading securities investment [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	357,000	42,000
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	18,176,000	18,340,000
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | US Treasury securities [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	17,819,000	18,298,000
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Trading securities investment [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	357,000	42,000
Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	0	0
Significant Other Observable Inputs (Level 2) [Member] | US Treasury securities [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	0	0
Significant Other Observable Inputs (Level 2) [Member] | Trading securities investment [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	0	0
Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	0	0
Significant Unobservable Inputs (Level 3) [Member] | US Treasury securities [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	0	0
Significant Unobservable Inputs (Level 3) [Member] | Trading securities investment [Member]	'	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'	'
Total financial assets measured at fair value	'	$0	$0

Income_Taxes_Income_Taxes_Deta

Income Taxes Income Taxes (Details)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Income Tax Disclosure [Abstract]	'	'
Estimated annual effective income tax rate	40.50%	'
Annual effective income tax rate	'	40.30%

Notes_Payable_and_Related_Cred1

Notes Payable and Related Credit Agreement (Details) (USD $)

1 Months Ended

6 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

Apr. 30, 2013

Apr. 30, 2012

Sep. 30, 2013

Apr. 30, 2012

Sep. 30, 2013

Apr. 08, 2013

Apr. 30, 2012

Apr. 09, 2013

Apr. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Apr. 08, 2013

Apr. 08, 2013

Sep. 30, 2013

Apr. 08, 2013

Apr. 08, 2013

Sep. 30, 2013

Sep. 30, 2013

Apr. 08, 2013

Apr. 08, 2013

Sep. 30, 2013

Apr. 08, 2013

Apr. 08, 2013

credit_facility

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Notes Payable to Banks [Member]

Notes Payable to Banks [Member]

Notes Payable to Banks [Member]

Letter of Credit [Member]

Letter of Credit [Member]

Minimum [Member]

Maximum [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

Base Rate [Member]

Base Rate [Member]

Base Rate [Member]

Base Rate [Member]

Base Rate [Member]

Base Rate [Member]

Base Rate [Member]

Notes Payable to Banks [Member]

Notes Payable to Banks [Member]

Notes Payable to Banks [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Notes Payable to Banks [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Notes Payable to Banks [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Notes Payable to Banks [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Notes Payable to Banks [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Notes Payable to Banks [Member]

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of credit facilities

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility, available

'

'

'

$50,000,000

'

'

$200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net of unamortized original issue discount

'

'

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rates spread over LIBOR and Base rate

'

'

'

'

'

'

'

'

'

'

'

3.00%

2.25%

3.75%

4.50%

2.75%

4.25%

4.75%

2.00%

1.25%

2.75%

3.50%

1.75%

3.25%

3.75%

Floor interest rates spread over borrowings under term loan

'

'

'

'

0.75%

1.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reduction in LIBOR floor

'

'

1.50%

'

0.50%

'

'

'

'

1.50%

1.75%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sublimit for swingline loans

'

'

'

'

'

'

'

30,000,000

20,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred finance costs incurred

935,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount of deferred financing costs to be capitalized and amortized

364,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Write off of deferred debt issuance cost

$434,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Treasury_Stock_Details

Treasury Stock (Details) (USD $)	3 Months Ended	6 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2013	Jun. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Treasury Stock Transactions, Excluding Value of Shares Reissued [Abstract]	'	'	'	'	'
Stock In Escrow For Indemnification Claims	'	'	'	'	457
Common Stock Released From Escrow	457	457	'	'	'
Treasury stock, shares	204	204	'	'	'
Common Stock Returned to Former Acquired Company's Selling Shareholders	253	253	'	'	'
Holdback settlement in equity from prior acquisition	$3,046	$3,046	$3,046	$0	'